← FDA Drug Approvals (Drugs@FDA)

NEVIRAPINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2017-08-03

Drug application

FDA Application #

ANDA207684

Application type

Abbreviated New Drug Application (Generic)

Brand name

NEVIRAPINE

Generic name

Nevirapine

Active ingredients

NEVIRAPINE

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

CIPLA

First approval

2017-08-03

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown